Literature DB >> 21865496

Thoracic epidural bupivacaine attenuates inflammatory response, intestinal lipid peroxidation, oxidative injury, and mucosal apoptosis induced by mesenteric ischemia/reperfusion.

Nurdan Bedirli1, Nalan Akyürek, Omer Kurtipek, Mustafa Kavutcu, Seyfi Kartal, Asli Cavunt Bayraktar.   

Abstract

BACKGROUND: We conducted this study to evaluate the effects of thoracic epidural anesthesia (TEA) on inflammatory response, lipid peroxidation, and oxidative stress in a rat model of mesenteric ischemia/reperfusion (I/R).
METHOD: Rats were divided into 4 groups: sham group (n=6; sham laparotomy), control group (n=6; I/R), bupivacaine group (n=6; mesenteric I/R and 20 μL/h 0.5% bupivacaine), and saline group (n=6, mesenteric I/R and 20 μL/h 0.9% saline). I/R injury was established by occluding the superior mesenteric artery for 1 hour followed by 12 hours reperfusion. Blood gas, tumor necrosis factor-α, interleukin-6, interleukin-1β, glutathione peroxidise, superoxide dismutase, catalese, myeloperoxidase concentrations, immunohistochemical examinations (intracellular adhesion molecule-1), apoptosis determination, and wet/dry ratio of intestinal edema were determined.
RESULTS: Bupivacaine significantly decreased the cytokine, malondialdehyde, and myeloperoxidase levels and increased the antioxidant enzyme levels. Wet/dry ratio comparison showed a significant decrease in the bupivacaine (2.88±0.17) group in comparison with control (5.45±0.67) and saline (5.87±0.17) groups. The intestinal injury score was significantly decreased in rats in the epidural bupivacaine (2 [1-2]) infusion group in comparison with rats in the control (3 [2-3]) and saline (3 [2-4]) groups. Bupivacaine (63%) caused a significant decrease in the percentage of apoptotic cells in comparison with control (85%) only. ICAM-1 levels in the bupivacaine (27.4±7.1) group decreased in comparison with control (12.3±7.4) and saline (24.9±3.2) groups.
CONCLUSION: This study demonstrated that epidural bupivacaine attenuates the mesenteric I/R-related inflammatory response and intestinal damage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865496     DOI: 10.1213/ANE.0b013e31822b8984

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  6 in total

1.  Tourniquet-induced ischemia-reperfusion injuries during extremity surgery at children's age: impact of anesthetic chemical structure.

Authors:  Ivana Budic; Dusica Pavlovic; Dusanka Kitic; Gordana Kocic; Tatjana Cvetkovic; Dusica Simic; Tatjana Jevtovic-Stoimenov
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

2.  The Effect of Spinal and General Anesthesia on Serum Lipid Peroxides and Total Antioxidant Capacity in Diabetic Patients with Lower Limb Amputation Surgery.

Authors:  Arash Peivandi Yazdi; Alireza Bameshki; Maryam Salehi; Gholamhosein Kazemzadeh; Majid Sharifian Razavi; Shaghayegh Rahmani; Seyed Isaac Hashemy
Journal:  Arch Bone Jt Surg       Date:  2018-07

3.  Impact of analgesic modality on stress response following laparoscopic colorectal surgery: a post-hoc analysis of a randomised controlled trial.

Authors:  J Barr; C Boulind; J D Foster; P Ewings; J Reid; J T Jenkins; B Williams-Yesson; N K Francis
Journal:  Tech Coloproctol       Date:  2015-02-26       Impact factor: 3.781

4.  Thoracic epidural block in sepsis: Looking beyond the known.

Authors:  Asha Tyagi
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2017 Apr-Jun

5.  Ultralow concentrations of bupivacaine exert anti-inflammatory effects on inflammation-reactive astrocytes.

Authors:  Linda Block; Per Jörneberg; Ulrika Björklund; Anna Westerlund; Björn Biber; Elisabeth Hansson
Journal:  Eur J Neurosci       Date:  2013-09-15       Impact factor: 3.386

6.  Thoracic epidural anesthesia decreases endotoxin-induced endothelial injury.

Authors:  Fabian Enigk; Antje Wagner; Rudi Samapati; Heike Rittner; Alexander Brack; Shaaban A Mousa; Michael Schäfer; Helmut Habazettl; Jörn Schäper
Journal:  BMC Anesthesiol       Date:  2014-04-05       Impact factor: 2.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.